CTP-692

DRUG4 trials

Sponsors

Concert Pharmaceuticals

Conditions

HealthyHealthy VolunteersSchizophrenia

Phase 1

A Study to Compare the Safety, Tolerability, and Pharmacokinetics of CTP-692 Versus D-serine in Healthy Volunteers

CompletedNCT03778320

Concert PharmaceuticalsHealthy Volunteers

Start: 2018-12-14End: 2019-01-31Updated: 2019-03-15

Study to Assess the Safety and Pharmacokinetic (PK) of CTP-692 in Healthy Volunteers

CompletedNCT03830463

Concert PharmaceuticalsHealthy

Start: 2019-01-24End: 2019-03-28Updated: 2019-06-13

Multiple Ascending Dose Study of CTP-692 in Healthy Volunteers

CompletedNCT03880253

Concert PharmaceuticalsHealthy

Start: 2019-04-10End: 2019-05-16Updated: 2019-06-13

Phase 2

A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-692 as an Adjunctive Treatment in Adults With Schizophrenia

CompletedNCT04158687

Concert PharmaceuticalsSchizophrenia

Start: 2019-11-26End: 2020-12-22Updated: 2023-12-22